Mein Warenkorb

Influenza B/Victoria Lineage Viruses Neuraminidase (NA) Specific ELISA Kit

User Reviews
Product Number/Spec
Price
Availability
Menge
RAS-A225-96tests
$780.00
In Stock - Delivery in 2-3 weeks
Gesamtanzahl Product Amount$ 0

Product Details

  • Materials Provided

    ID
    Components
    Size
    RAS225-C01
    Pre-coated Anti-NA (Influenza B/Austria/1359417/2021) Antibody Microplate
    1 plate(8×12 strips)
    RAS225-C02
    NA (Influenza B/Austria/1359417/2021) Standard
    20 μg
    RAS225-C03
    HRP-Anti-NA (Influenza B/Austria/1359417/2021) Antibody
    15 μg
    RAS225-C04
    10×Washing Buffer
    50 mL
    RAS225-C05
    2×Dilution Buffer
    50 mL
    RAS225-C06
    Substrate Solution
    12 mL
    RAS225-C07
    Stop Solution
    7 mL

  • Product Overview

    Influenza B/Victoria Lineage Viruses Neuraminidase (NA) Specific ELISA Kit is designed for quantitative detection of antigen and quality control of vaccines.It is based on sandwich-ELISA technology platform to realize the quantitative detection of NA protein in samples.

  • Application

    This kit is developed for Specific quantitative detection of Influenza B/Victoria Lineage Viruses Neuraminidase (NA) in samples.

    It is for research use only.

  • Storage

    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Kunden haben auch angesehen

Data Display

  • Typical Data 

    Please refer to DS document for the assay protocol.

     Neuraminidase/NA (Influenza Virus) TYPICAL DATA

    For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The following example data is for reference only.

  •  Neuraminidase/NA (Influenza Virus) TYPICAL DATA

    The kit has been tested to specifically identify Influenza B [Austria/1359417/2021] NA, and do not identify Influenza B [PHUKET/3073/2013] NA, Influenza A [A/Victoria/4897/2022(H1N1)] NA, Influenza A [Wisconsin/67/2022(H1N1)] NA, Influenza A (A/Croatia/10136RV/2023) & (A/District of Columbia/27/2023) NA(H3N2), Influenza A virus (A/Massachusetts/18/2022) NA(H3N2), Influenza A (A/Thailand/8/2022) NA(H3N2), Influenza A [Darwin/6/2021] NA and Influenza A [A/Darwin/9/2021 (H3N2)] NA.

User Reviews
Publish Comment

Frontier Progress

 
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Kunden haben auch angesehen
  • Data Display
  • User Reviews
Kontaktieren Sie uns